Lactobacillus rhamnosus
Minimum 10 billion CFU of Lactobacillus rhamnosusbacteria
Important Information for the Patient.
This medication should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Lakcid Forte is a medication in the form of hard capsules for oral use. It contains Lactobacillus rhamnosusstrains, which, like other lactic acid bacteria, colonize the intestinal mucosa and normalize the composition of the gut microflora, especially after its depletion due to antibiotic therapy. The results of studies have confirmed that these strains survive in the gastric juice environment and are resistant to the action of bile salts, which enables them to adapt and survive in the gastrointestinal tract.
By competing for substrates and colonization sites on the intestinal mucosa and producing lactic acid as a result of anaerobic sugar decomposition, they create unfavorable conditions for the development of most pathogenic microorganisms.
These strains have natural resistance to a wide range of clinically used antibiotics.
Lakcid Forte is intended for use:
Before starting treatment with Lakcid, the patient should discuss it with their doctor.
There is a risk of bacteremia (sepsis). Single cases of infectious endocarditis in a patient in severe condition caused by Lactobacillus rhamnosusinfection have been reported.
Treatment with a medication containing Lactobacillus rhamnosusmay, in exceptional cases, cause septic infections in patients at increased risk, mainly in premature infants and children born at term but with defects or impaired organ function.
The medication is taken independently of meal times.
The medication can be used during pregnancy and breastfeeding.
Lakcid Forte does not affect the ability to drive and operate machinery.
If the patient has previously been diagnosed with intolerance to certain sugars, they should consult their doctor before taking the medication.
The medication may cause allergic reactions.
This medication should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
Recommended dose
If the doctor does not recommend otherwise, 2 times a day, one dose (contents of a capsule or the entire capsule).
The medication is taken orally.
The capsule should be swallowed whole, washed down with boiled and cooled water or milk at room temperature.
The contents of the capsule (powder) can be dissolved in about 1/8 cup of boiled and cooled water or milk at room temperature, mixed thoroughly. This method of administration is especially recommended for infants and children.
In the case of administering the medication to infants and children, the contents of the capsule (powder) should be dissolved in about 1/8 cup of boiled and cooled water or milk at room temperature, mixed thoroughly.
No cases of overdose have been reported.
Like all medications, Lakcid Forte can cause side effects, although not everybody gets them.
The following side effects may occur
Frequency not known (frequency cannot be estimated from the available data):
If any side effects occur, including those not listed in this leaflet, the patient should inform their doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medication.
The medication should be stored out of sight and reach of children.
The medication should not be used after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
Store in a refrigerator (2°C - 8°C).
Within the validity period, the medication can be stored for 1 month at a temperature of 15°C - 25°C.
Medications should not be disposed of in wastewater or household waste containers. The patient should ask their pharmacist how to dispose of unused medications. This will help protect the environment.
Each capsule contains:
minimum 10 billion CFU of Lactobacillus rhamnosusbacteria:
Lactobacillus rhamnosusPen strain
CFU - Colony Forming Unit.
The medication is in the form of cellulose, hard capsules.
Before reconstitution, the powder in the capsule is in the form of loose, powdered particles with a color ranging from light to dark beige.
After reconstitution, a homogeneous suspension is formed, without visible impurities.
Package sizes:
1 blister pack of 5 capsules with 1 dose of powder
1 blister pack of 10 capsules with 1 dose of powder
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Synthaverse S.A.
Uniwersytecka 10, 20-029 Lublin
Date of last update of the leaflet:June 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.